Beyond the diagnosis: planning for life with multiple sclerosis
The quality of patient care depends not only on effective treatments but also on timely diagnoses, access to innovation and social inclusion
Key points
Over the last twenty years, research has profoundly changed the course of the disease. Early diagnosis and the availability of increasingly effective treatments now make it possible to alter the course of multiple sclerosis and to preserve independence, relationships, employment and quality of life for longer. This progress, however, brings with it a new responsibility: if the history of the disease changes, the system’s response must change too.
This is the vision set out in the 2030 Agenda for Multiple Sclerosis and Related Conditions. The aim is not merely to make innovation and knowledge available, but to ensure that they translate into a tangible improvement in quality of life for all people with multiple sclerosis and related conditions. To this end, the Agenda sets out a number of strategic priorities: ensuring equitable access to treatments, strengthening Diagnostic, Therapeutic and Care Pathways (PDTA), developing genuine integration between healthcare and social services, and ensuring that everyone can shape their own life plan.
The role of research goes beyond new treatments
Research is not just about new treatments. It means gaining a better understanding of disease, improving the organisation of services, developing more effective care models, and shaping health policies on the basis of evidence. It is the ‘lever of levers’ in the 2030 Agenda because it makes it possible to develop policies tailored to people’s real needs.
At a session of the 79th World Health Assembly in Geneva on 22 May, multiple sclerosis was cited as a benchmark for defining responses to neurological diseases and, in many respects, to chronic conditions as well. This is an important recognition that highlights the progress made over the years and the potential to apply this experience to other areas of neurology. The quality of care, in fact, depends not only on the effectiveness of treatments, but also on the system’s ability to ensure timely diagnosis, access to innovation, multidisciplinary care pathways, rehabilitation, continuity of care and social inclusion. It is this integrated approach that makes multiple sclerosis a benchmark today.
Disability reform
Italia’s disability reform fits into this context and represents an extraordinary opportunity for change. The individual, personalised and participatory life plan introduces a new way of viewing the person: no longer defined solely by their health condition, but recognised in their entirety – in their aspirations, relationships, education, work and participation in community life. For those living with multiple sclerosis, this means working with services to develop personalised solutions that integrate healthcare, social support and opportunities for inclusion. It is a cultural shift even before it is an organisational one, requiring stable collaboration between institutions, the scientific community and user organisations.

